INFLUENCE OF SYNBIOTIC CONTAINING LACTOBACILLUS RHAMNOSUS GG IN CONTROLLING THE SYMPTOMS OF ATOPIC DERMATITIS OF MODERATE SEVERITY IN CHILDREN
https://doi.org/10.21518/2079-701X-2018-2-229-232
Abstract
The article presents the results of research of influence of synbiotic containing Lactobacillus rhamnosus GG in controlling the symptoms of atopic dermatitis of moderate severity in children. The study included children (n = 20) with atoral dermatitis of moderate severity. The studied patients were divided into 2 groups: group 1 (n = 10) received synbiotic containing Lactobacillus rhamnosus GG in combination with topical anti-inflammatory therapy and the hypoallergenic diet group 2 (n = 10) received topical anti-inflammatory therapy and the hypoallergenic diet. When comparing the data obtained in the group of children treated with synbiotic containing Lactobacillus rhamnosus GG and the control group obtained a significant decrease of the SCORAD index by the end of 2 weeks (p1<0,01) in group 1. Reliable clinical positive dynamics in patients of the 2nd group was mentioned only at the end of the 3rd week.
About the Authors
O. A. Pritulo
V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
MD, Prof.
L. K. Znamenskaya
V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
PhD in medicine
Yakin Marwan Naji Marakah
V.I. Vernadsky Crimean Federal University
Russian Federation
Russian Federation
PhD in medicine
I. V. Rychkova
GBUZ RK «KKVD» Russia
Russian Federation
Russian Federation
Simferopol
References
1. Федеральные клинические рекомeндации. Дерматовенерология 2015 г. Болезни кожи. Инфекции, передаваемые половым путем. 5-е изд., перераб. и доп. М.: Деловой экспресс, 2016. 768 с.
2. Кубанова А.А. Анализ эпидемиологической ситуации и динамика заболеваемости инфекциями, передаваемыми половым путем, болезнями кожи и подкожной клетчатки населения Российской Федерации по данным официальной государственной статистики. Вестник дерматологии и венерологии, 2008, 5: 8-18.
3. Langhendries JP. Allergy prevention: is the game over early at birth. Arch. Pediatr, 2001, 8: 1037-1041.
4. Strachan DP. Hay fever, hygiene and household size. BMJ, 1989, 299: 1259-1260.
5. Kummeling I, Thijs C, Penders J at al. Etiology of atopy in infancy: the KOALA Birth Cohort Study. Pediatr Allergy Immunol, 2005, 16: 679-684.
6. Legatzki A, Rösler B, von Mutius E. Microbiome diversity and asthma and allergy risk. Curr. Allergy Asthma Rep, 2014, 14(10): 466.
7. Знаменская Л.К. Состояние микробиоценоза кишечника у пациентов с атопическим дерматитом в зависимости от степени тяжести заболевания. Таврический медико-биологический вестник, 2013, 1: 80-82.
8. Алешкин А.А., Афанасьев С.С., Караулов А.В. Микробиоценозы человека и здоровье человека. М., 2015, 547 с.
9. Zeeuwen PL, Kleerebezem M, Timmerman HM, Schalkwijk J. Microbiome and skin diseases. Curr Opin Allergy Clin Immunol, 2013, 13(5): 514–520.
10. Delcenarie V, Martel D, Lamoureux M, et al. Immunomodulatory effect of probiotics in the intestinal tract. Curr Issues Mol Biol, 2008, 10: 37-54.
11. Kalliomaki M, Salminen S, Pousssa T, Arvilommi H, Isolauri E. Probiotic and prevention of atopic disease: 4-years follow-up of randomized placebo-controlled trial. Lancet, 2003, 361: 1869-1871.
12. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in management of atopic eczema. Clinical and Experimental Allergy, 2000, 30: 1604-1610.
13. Хавкин А.И. Микроэкология кишечника и аллергия. Лечащий врач, 2003, 2: 14-16.
14. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol., 1997, 99: 179-185.
15. Johnson-Henry KC, Donato KA, Shen-Tu G, еt al. Lactobacillus rhamnosus strein GG prevents enterohemorrhagic Esherichia Coli O157:H7-induced chages in epithelial barrier function. Infect. immune., 2008, 76: 1340-1348.
16. Rakoff-Nahoum S, Paglino J, Eslami-Yarzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell, 2004, 118: 229-241.
17. Oksaharji A, Kankainen M, Kekkonen RA et al. Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cell. World J. Gastroenterol., 2011, 17: 750-759.
18. Oksaharji A, Kankainen M, Kekkonen RA et al. Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cell. World J. Gastroenterol., 2011, 17: 750-759.
19. Pessi T, Sutas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy, 2000, 30: 1804-1808.
20. Pelto L, Isolaury E, Lilius EM et al. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk hypersensitive subject but have an immunostimulatory effect in healthy subject. Clin. Exp. Allergy, 1998, 28: 1474-1479.
21. Федеральные клинические рекомендации. Аллергология. М., 2014. 124 с.
22. htth://medspecial.ru/for_dopctors/149/27847/
Review
For citations:
Pritulo OA, Znamenskaya LK, Marakah Y, Rychkova IV. INFLUENCE OF SYNBIOTIC CONTAINING LACTOBACILLUS RHAMNOSUS GG IN CONTROLLING THE SYMPTOMS OF ATOPIC DERMATITIS OF MODERATE SEVERITY IN CHILDREN. Meditsinskiy sovet = Medical Council. 2018;(2):229-232. (In Russ.) https://doi.org/10.21518/2079-701X-2018-2-229-232
Views:
800
Email this article 